These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis. Kalowski S; Kincaid-Smith P Med J Aust; 1973 Jul; 2(4):164-6. PubMed ID: 4741342 [No Abstract] [Full Text] [Related]
28. Comparison of two laboratory tests in the control of anticoagulant therapy. Pearce SJ; Sekar AS J Clin Pathol; 1973 Jan; 26(1):73-6. PubMed ID: 4693900 [TBL] [Abstract][Full Text] [Related]
29. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism. Rosen RL J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753 [TBL] [Abstract][Full Text] [Related]
30. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W; N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010 [TBL] [Abstract][Full Text] [Related]
31. [Coagulological aspects of treatment of complications of prolonged therapy with warfarin]. Krylov AIu; Shulutko AM; Prasolov NV; Petrovskaia AA; Khmyrova SE Angiol Sosud Khir; 2016; 22(3):33-41. PubMed ID: 27626247 [TBL] [Abstract][Full Text] [Related]
32. Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation. Hitaka Y; Ogawa M; Zhang B; Goto S; Nagata Y; Morii J; Imaizumi S; Yasuda T; Matsumoto N; Matsunaga A; Saku K J Cardiol; 2016 Dec; 68(6):529-535. PubMed ID: 26987789 [TBL] [Abstract][Full Text] [Related]
33. Considerations for using lower doses of warfarin. Bern MM Hematol Oncol Clin North Am; 1992 Oct; 6(5):1105-14. PubMed ID: 1400074 [TBL] [Abstract][Full Text] [Related]
34. [Indications for and hazards of anticoagulant therapy]. Straub PW Schweiz Med Wochenschr; 1970 Apr; 100(16):686-91. PubMed ID: 4258885 [No Abstract] [Full Text] [Related]
35. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
36. Current concepts of warfarin therapy. Peterson CE; Kwaan HC Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of venous thrombosis with low molecular weight heparin and fluindione]. Fiessinger JN; Paul JF; Alhenc-Gelas M; Veyssier C; Martin JB; Aiach M Presse Med; 1992 Jan; 21(2):65-8. PubMed ID: 1311080 [TBL] [Abstract][Full Text] [Related]
38. Therapy of deep vein thrombosis. Turpie AG Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442 [TBL] [Abstract][Full Text] [Related]